CoChat

Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice

Open access
Schafer, Marissa J., Alldred, Melissa J., Lee, Sang Han, Calhoun, Michael E., Petkova, Eva, Mathews, Paul M., Ginsberg, Stephen D. · 2015 · Neurobiology of Aging
Cited by 97

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Research indicates that female risk of developing Alzheimer’s disease (AD) is greater than that of males. Moderate reduction of calorie intake, known as calorie restriction (CR), reduces pathology in AD mouse models, and is a potentially translatable prevention measure for individuals at-risk for AD, as well as an important tool for understanding how the brain endogenously attenuates age-related pathology. Whether sex influences the response to CR remains unknown. In this study, we assessed the effect of CR on beta-amyloid peptide (Aβ) pathology and hippocampal CA1 neuron specific gene expression in the Tg2576 mouse model of cerebral amyloidosis. Relative to ad libitum (AL) feeding, CR feeding significantly reduced hippocampal Aβ burden in 15 month old female, but not age-matched male, Tg2576 mice. Sustained CR also significantly reduced expression of presenilin enhancer 2 (Psenen) and presenilin 1 (Ps1), components of the γ-secretase complex, in Tg2576 females. These results indicate that long-term CR significantly reduces age-dependent female Tg2576 Aβ pathology, which is likely to involve CR-mediated reductions in γ-secretase-dependent amyloid precursor protein (APP) metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2014.10.043

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 64

  1. Alldred, 2008, Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain, Int. J. Mol. Sci., 9, 2091, 10.3390/ijms9112091 · DOI · Paper page
  2. Alldred, 2009, Terminal continuation (TC) RNA amplification without second strand synthesis, J. Neurosci. Methods, 177, 381, 10.1016/j.jneumeth.2008.10.027 · DOI · Paper page
  3. Alldred, 2012, Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction, Neurobiol. Dis., 45, 751, 10.1016/j.nbd.2011.10.022 · DOI · Paper page
  4. Alldred, 2014, Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD), Brain Struct. Funct.
  5. Azad, 2007, Gender differences in dementia risk factors, Gend. Med., 4, 120, 10.1016/S1550-8579(07)80026-X · DOI · Paper page
  6. Balducci, 2011, The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice, J. Alzheimers. Dis., 24, 799, 10.3233/JAD-2011-101839 · DOI
  7. Bartley, 2012, Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade, J. Alzheimers. Dis., 28, 855, 10.3233/JAD-2011-111172 · DOI
  8. Calhoun, 1998, Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice, Neurobiol Aging, 19, 599, 10.1016/S0197-4580(98)00098-0 · DOI · Paper page
  9. Chow, 2010, An overview of APP processing enzymes and products, Neuromolecular Med., 12, 1, 10.1007/s12017-009-8104-z · DOI · Paper page
  10. Crump, 2013, Development and mechanism of γ-secretase modulators for Alzheimer's disease, Biochemistry, 52, 3197, 10.1021/bi400377p · DOI · Paper page
  11. De LaCoste, 1993, The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system, Neurobiol. Aging, 14, 1, 10.1016/0197-4580(93)90015-4 · DOI · Paper page
  12. Dewachter, 2002, Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice, J. Neurosci., 22, 3445, 10.1523/JNEUROSCI.22-09-03445.2002 · DOI · Paper page
  13. Ding, 2013, Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's, PLoS One, 8, e59825, 10.1371/journal.pone.0059825 · DOI · Paper page
  14. Esler, 2000, Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1, Nat. Cell Biol., 2, 428, 10.1038/35017062 · DOI · Paper page
  15. Francis, 2002, aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation, Dev. Cell, 3, 85, 10.1016/S1534-5807(02)00189-2 · DOI · Paper page
  16. Ginsberg, 2005, RNA amplification strategies for small sample populations, Methods, 37, 229, 10.1016/j.ymeth.2005.09.003 · DOI
  17. Ginsberg, 2008, Transcriptional profiling of small samples in the central nervous system, Methols Mol. Biol., 439, 147, 10.1007/978-1-59745-188-8_10 · DOI · Paper page
  18. Ginsberg, 2012, Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease, Neurobiol. Dis., 45, 99, 10.1016/j.nbd.2011.07.013 · DOI · Paper page
  19. Ginsberg, 2010, Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression, Biol. Psychiatry, 68, 885, 10.1016/j.biopsych.2010.05.030 · DOI · Paper page
  20. Ginsberg, 2005, Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons, J. Comp. Neurol., 487, 107, 10.1002/cne.20535 · DOI · Paper page
  21. Ginsberg, 2006, Down regulation of Trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease, J. Neurochem., 97, 475, 10.1111/j.1471-4159.2006.03764.x · DOI · Paper page
  22. Ginsberg, 2000, Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons, Ann. Neurol., 48, 77, 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A · DOI · Paper page
  23. Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
  24. Golde, 2013, γ-Secretase inhibitors and modulators, Biochim. Biophys. Acta, 1828, 2898, 10.1016/j.bbamem.2013.06.005 · DOI · Paper page
  25. Good, 2007, The “Swedish” mutation of the amyloid precursor protein (APPswe) dissociates components of object-location memory in aged Tg2576 mice, Behav. Neurosci., 121, 1180, 10.1037/0735-7044.121.6.1180 · DOI · Paper page
  26. Götz, 2009, Alzheimer's disease selective vulnerability and modeling in transgenic mice, J. Alzheimers. Dis., 18, 243, 10.3233/JAD-2009-1143 · DOI · Paper page
  27. Goutte, 2002, APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos, Proc. Natl. Acad. Sci. U. S. A., 99, 775, 10.1073/pnas.022523499 · DOI · Paper page
  28. Gundersen, 1988, The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use, APMIS, 96, 857, 10.1111/j.1699-0463.1988.tb00954.x · DOI · Paper page
  29. Gustafson, 2003, An 18-year follow-up of overweight and risk of Alzheimer disease, Arch. Intern. Med., 163, 1524, 10.1001/archinte.163.13.1524 · DOI · Paper page
  30. Hart, 1999, Adaptive role of caloric intake on the degenerative disease processes, Toxicol. Sci., 52, 3, 10.1093/toxsci/52.2.3 · DOI
  31. Hemby, 2003, Neuron-specific age-related decreases in dopamine receptor subtype mRNAs, J. Comp. Neurol., 456, 176, 10.1002/cne.10525 · DOI · Paper page
  32. Hirata-Fukae, 2008, Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model, Brain Res., 1216, 92, 10.1016/j.brainres.2008.03.079 · DOI · Paper page
  33. Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 7, 10.1126/science.274.5284.99 · DOI · Paper page
  34. Irizarry, 2001, beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging, Am. J. Pathol., 158, 173, 10.1016/S0002-9440(10)63955-7 · DOI
  35. Kacharmina, 1999, Preparation of cDNA from single cells and subcellular regions, Methods Enzymol., 303, 3, 10.1016/S0076-6879(99)03003-7 · DOI · Paper page
  36. Kealy, 2002, Effects of diet restriction on life span and age-related changes in dogs, J. Am. Vet. Med. Assoc., 220, 1315, 10.2460/javma.2002.220.1315 · DOI · Paper page
  37. Klass, 1977, Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span, Mech. Ageing Dev., 6, 413, 10.1016/0047-6374(77)90043-4 · DOI · Paper page
  38. Kunzler, 2014, APOE modulates the effect of estrogen therapy on Aβ accumulation, Neurosci. Lett., 560, 131, 10.1016/j.neulet.2013.12.032 · DOI · Paper page
  39. Lee, 1987, Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats, J. Neurosci., 7, 3474, 10.1523/JNEUROSCI.07-11-03474.1987 · DOI · Paper page
  40. Lee, 2002, Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 99, 7705, 10.1073/pnas.092034699 · DOI · Paper page
  41. Li, 2003, Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals, J. Neurosci., 23, 3272, 10.1523/JNEUROSCI.23-08-03272.2003 · DOI · Paper page
  42. Li, 2000, Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1, Nature, 405, 689, 10.1038/35015085 · DOI · Paper page
  43. Marlow, 2003, APH1, PEN2, and Nicastrin increase Aβ levels and γ-secretase activity, Biochem. Biophys. Res. Commun., 305, 502, 10.1016/S0006-291X(03)00797-6 · DOI
  44. Mathews, 2002, Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments, J. Biol. Chem., 277, 36415, 10.1074/jbc.M205208200 · DOI · Paper page
  45. Mikulca, 2014, Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches, J. Clin. Pharm. Ther., 39, 25, 10.1111/jcpt.12112 · DOI · Paper page
  46. Morales-Corraliza, 2009, In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice, PLoS One, 4, e7134, 10.1371/journal.pone.0007134 · DOI · Paper page
  47. Morrison, 2002, Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease, Prog. Brain Res., 136, 467, 10.1016/S0079-6123(02)36039-4 · DOI · Paper page
  48. Mouton, 2009, Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice, Neurosci. Lett., 464, 184, 10.1016/j.neulet.2009.08.038 · DOI · Paper page
  49. Patel, 2005, Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models, Neurobiol. Aging, 26, 995, 10.1016/j.neurobiolaging.2004.09.014 · DOI · Paper page
  50. Pedrini, 2009, Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology, Mol. Neurodegener., 4, 40, 10.1186/1750-1326-4-40 · DOI · Paper page
  51. Placanica, 2009, Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease, PLoS One, 4, e5088, 10.1371/journal.pone.0005088 · DOI · Paper page
  52. Rajendran, 2012, Membrane trafficking pathways in Alzheimer's disease, Traffic, 13, 759, 10.1111/j.1600-0854.2012.01332.x · DOI · Paper page
  53. Roe, 1995, The Biosure Study: influence of composition of diet and food consumption on longevity, degenerative diseases and neoplasia in Wistar rats studied for up to 30 months post weaning, Food Chem. Toxicol., 33, 1S, 10.1016/0278-6915(94)00139-F · DOI
  54. Rous, 1914, The influence of diet on transplanted and spontaneous mouse tumors, J. Exp. Med., 20, 433, 10.1084/jem.20.5.433 · DOI · Paper page
  55. Schmidt, 2012, Abeta measurement by enzyme-linked immunosorbent assay, Methods Mol. Biol., 849, 507, 10.1007/978-1-61779-551-0_34 · DOI · Paper page
  56. Shiraishi, 2004, PEN-2 enhances gamma-cleavage after presenilin heterodimer formation, J. Neurochem., 90, 1402, 10.1111/j.1471-4159.2004.02597.x · DOI
  57. Sivilia, 2013, Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice, BMC Neurosci., 14, 1, 10.1186/1471-2202-14-44 · DOI
  58. Steiner, 2002, PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin, J. Biol. Chem., 277, 39062, 10.1074/jbc.C200469200 · DOI · Paper page
  59. Viña, 2010, Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide, J. Alzheimers. Dis., 20, S527, 10.3233/JAD-2010-100501 · DOI · Paper page
  60. Wan, 2011, β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease, Free Radic. Biol. Med., 50, 122, 10.1016/j.freeradbiomed.2010.10.707 · DOI
  61. Wang, 2005, Caloric restriction attenuates ß-amyloid neuropathology in a mouse model of Alzheimer's disease, FASEB J., 18, 1, 10.1096/fj.04-2370com · DOI · Paper page
  62. Wolf, 2012, Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention, J. Alzheimers. Dis., 32, 217, 10.3233/JAD-2012-120478 · DOI
  63. Yue, 2005, Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model, Proc. Natl. Acad. Sci. U. S. A., 102, 19198, 10.1073/pnas.0505203102 · DOI · Paper page
  64. Zhang, 2000, Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1, Nat. Cell Biol., 2, 463, 10.1038/35017108 · DOI · Paper page

Cited by

See all 97

Metadata

Authors
Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2015-03
Volume
36
Issue
3
Pages
1293-1302
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2101531721
Cited by
97
References
31
FWCI
2.72
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • NIH (GM007238, RR029893, AG043375, AG014449, AG017617, HD057564)
  • Alzheimer's Association (IIRG-12–237253)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2014.10.043
The paper
Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D. (2015). Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2014.10.043

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.